Clinical Trials Logo

Clinical Trial Summary

The investigators aim to evaluate efficacy of TMS as an adjunct to CIMT, assess its safety and tolerability and study cortical excitability with help of TMS which are both rehabilitative therapies for hemiplegic cerebral palsy.


Clinical Trial Description

Cerebral palsy is the most common motor disability of childhood and Hemiparetic cerebral palsy accounts for about one third of cases. Improving spasticity and upper limb function in these children can lead to better functional outcome and quality of life. TMS is an upcoming rehabilitative modality which has shown promising results in western studies. It has benefits of being non-invasive and has shown to have additive effect when used with CIMT which is standard of care in hemiparetic CP. However, randomized controlled clinical trials comparing it with CIMT alone in hemiparetic CP are very few, none from India so far. The dose, type and duration of TMS and its feasibility in resource limited set up needs to be investigated in children .Therefore, the investigators aim to evaluate efficacy of TMS as an adjunct to CIMT, assess its safety and tolerability and study cortical excitability with help of TMS. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03792789
Study type Interventional
Source All India Institute of Medical Sciences, New Delhi
Contact Sheffali Gulati, MD
Phone 09810386847
Email sheffaligulati@gmail.com
Status Not yet recruiting
Phase N/A
Start date January 15, 2019
Completion date August 30, 2020

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05349136 - Telerehabilitation-Based Action Observation Treatment in Children With Hemiparetic Cerebral Palsy N/A
Not yet recruiting NCT06438666 - Effects Obtained at Manual Function After Applying Anodic Transcranial Direct Current Stimulation (tCDS) in Children With Spastic Hemiparetic Cerebral Palsy N/A
Completed NCT00991692 - A Multisite Trial of ACQUIREc Therapy N/A